MedPath

Prospective observational study of functional decline and disabilities in the elderly living with lung cancer.

Not Applicable
Conditions
on-small cell lung cancer
Registration Number
JPRN-UMIN000009768
Lead Sponsor
Shizuoka Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) They can not be done a physical assessment. 2) Having symptomatic brain metastasis.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of patients with physical functional decline or disabilities after 4 to 8 weeks after initiating chemotherapy.
Secondary Outcome Measures
NameTimeMethod
The proportion of patients with physical functional decline or disabilities after 12 and 24 weeks after initiating chemotherapy.
© Copyright 2025. All Rights Reserved by MedPath